IMMUNOVANT INC (IMVT) Stock Analyst Ratings
NASDAQ:IMVT - Nasdaq - US45258J1025 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to IMVT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 46.14. This target is 192% above the current price.
IMVT was analyzed by 21 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about IMVT.
In the previous month the buy percentage consensus was at a similar level.
IMVT was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-22 | UBS | Downgrade | Buy -> Neutral |
| 2025-03-20 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-20 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-10 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-02-10 | Guggenheim | Maintains | Buy -> Buy |
| 2025-02-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-15 | B of A Securities | Maintains | Buy -> Buy |
| 2025-01-03 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2024-12-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-10 | Raymond James | Reiterate | Outperform |
| 2024-10-09 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-09-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-13 | UBS | Maintains | Buy -> Buy |
| 2024-08-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-07 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-18 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-30 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-05-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-28 | Oppenheimer | Initiate | Outperform |
| 2024-03-25 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-03-13 | Goldman Sachs | Initiate | Buy |
| 2024-02-20 | JP Morgan | Initiate | Overweight |
| 2024-02-15 | Wolfe Research | Initiate | Outperform |